v3.26.1
Net Income (Loss) Per Share (Tables)
 12 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of net income (loss) per share for the periods presented:
Year Ended June 30,
(in thousands, except per share amounts)
202620252024
Numerator:
Net income (loss) attributable to common shareholders, basic$(11,649)$25,032 $(34,125)
Change in fair value of warrants(1)
— (22,607)— 
Net income (loss) attributable to common shareholders, diluted(11,649)2,425 (34,125)
Denominator:
Weighted-average common stock outstanding, basic188,174 176,148 168,519 
Stock options outstanding to purchase shares of common stock including unvested RSUs and from the ESPP(2)
— 4,458 — 
Dilutive effect of warrants to purchase common stock— 1,289 — 
Weighted-average common stock outstanding, diluted
188,174 181,895 168,519 
Net income (loss) per share—basic:$(0.06)$0.14 $(0.20)
Net income (loss) per share—diluted:$(0.06)$0.01 $(0.20)
(1) Includes the change in fair value of warrant liabilities to the extent the related warrants to purchase common stock are dilutive or the effect is not anti-dilutive.
(2) Excluded from the computation of net income (loss) per share-diluted for the year ended June 30, 2026, and June 30, 2024, because the effect would have been anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Income (Loss) Per Share
The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following:
Year Ended June 30,
(in thousands)202620252024
Stock options outstanding to purchase shares of common stock, unvested RSUs and shares from the ESPP
12,817 3,799 12,204 

The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted because the performance or market conditions associated with these awards were not met are as follows for the periods presented:
Year Ended June 30,
(in thousands)202620252024
Shares subject to outstanding PVUs
8,463 7,437 6,243 

The weighted average potential shares of common stock that were excluded from the calculation of net income (loss) per share-diluted because the exercise price of the warrants exceeded the average market price of the Company's common stock or the effect would have been anti-dilutive for the periods presented:
Year Ended June 30,
(in thousands)202620252024
Warrants to purchase shares of common stock21,843 8,932 —